Onconetix (ONC) Shares Drop After Announcing Realbotix Acquisition

Onconetix (ONC) closed 22.4% lower at $12.50 on February 12, 2026, following the announcement of its acquisition of Realbotix for $35 million in stock. The deal, valued at $42 million, was aimed at expanding the company's robotic automation capabilities. Shareholders reacted sharply to the significant dilution expected from the stock swap, with the stock hitting a session low of $12.25. The transaction is pending regulatory approval and is expected to close within the next 30 days.